Acadia Pharmaceuticals
ACAD
ACAD
193 hedge funds and large institutions have $3.17B invested in Acadia Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 63
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Holders
193
Holding in Top 10
4
Calls
$45.7M
Puts
$32.2M
Top Buyers
| 1 | +$121M | |
| 2 | +$68.7M | |
| 3 | +$40M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$24.6M |
| 5 |
HM
HealthCor Management
New York
|
+$23.6M |
Top Sellers
| 1 | -$93.9M | |
| 2 | -$44.2M | |
| 3 | -$41M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.5M |
| 5 |
Bank of New York Mellon
New York
|
-$24.2M |